| Mr Sean Lyon, APRN | |
|
276 Newport Rd, Ste 107, New London, NH 03257-5468 | |
| (603) 526-4144 | |
| (603) 526-4167 |
| Full Name | Mr Sean Lyon |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner - Family |
| Location | 276 Newport Rd, New London, New Hampshire |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023135878 | NPI | - | NPPES |
| 047202 | Other | NH | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 047202-23-03 (New Hampshire) | Primary |
| Entity Name | Life Long Care Of New London Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366634776 PECOS PAC ID: 5395789440 Enrollment ID: O20050620000303 |
News Archive
In particularly aggressive forms of breast cancer, cancer cells can settle in other organs and form metastases there. Once such metastases form, complete recovery is rare. Consequently, it is enormously important to prevent the metastasisation of the breast cancer cells. The success, however, achieved by using existing forms of therapy is limited.
"The Kenyan government will begin distributing free syringes and needles to more than 50,000 [injection] drug users (IDUs) across the country in the next month," PlusNews reports, adding, "Policy-makers and experts said the decision was reached following concerns over the spread of HIV and other blood-borne illnesses through injection drug use."
Parabon NanoLabs, a leading designer and manufacturer of breakthrough products at the nanoscale, announced today its award of a National Science Foundation (NSF) Small Business Innovative Research (SBIR) grant.
AMAG Pharmaceuticals, Inc. today reported preliminary results from the second phase III study from its global registrational program for Feraheme (ferumoxytol) in patients with iron deficiency anemia (IDA) regardless of the underlying cause.
When variants of SARS-CoV-2 (the virus that causes COVID-19) emerged in late 2020, concern arose that they might elude protective immune responses generated by prior infection or vaccination, potentially making re-infection more likely or vaccination less effective.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Sean Lyon, APRN 276 Newport Rd, Ste 107, New London, NH 03257-5468 Ph: (603) 526-4144 | Mr Sean Lyon, APRN 276 Newport Rd, Ste 107, New London, NH 03257-5468 Ph: (603) 526-4144 |
News Archive
In particularly aggressive forms of breast cancer, cancer cells can settle in other organs and form metastases there. Once such metastases form, complete recovery is rare. Consequently, it is enormously important to prevent the metastasisation of the breast cancer cells. The success, however, achieved by using existing forms of therapy is limited.
"The Kenyan government will begin distributing free syringes and needles to more than 50,000 [injection] drug users (IDUs) across the country in the next month," PlusNews reports, adding, "Policy-makers and experts said the decision was reached following concerns over the spread of HIV and other blood-borne illnesses through injection drug use."
Parabon NanoLabs, a leading designer and manufacturer of breakthrough products at the nanoscale, announced today its award of a National Science Foundation (NSF) Small Business Innovative Research (SBIR) grant.
AMAG Pharmaceuticals, Inc. today reported preliminary results from the second phase III study from its global registrational program for Feraheme (ferumoxytol) in patients with iron deficiency anemia (IDA) regardless of the underlying cause.
When variants of SARS-CoV-2 (the virus that causes COVID-19) emerged in late 2020, concern arose that they might elude protective immune responses generated by prior infection or vaccination, potentially making re-infection more likely or vaccination less effective.
› Verified 5 days ago
Elizabeth Ann Falicon, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 276 Newport Rd, Suite 107, New London, NH 03257 Phone: 603-526-4144 | |
Samantha Marie Rossignol, APRN, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 273 County Rd, New London, NH 03257 Phone: 603-526-2911 | |
Ms. Arlene Halsted, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 273 County Rd, New London, NH 03257 Phone: 603-526-5215 | |
Griffin Manning, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 273 County Rd, New London, NH 03257 Phone: 603-526-5544 Fax: 603-526-5085 | |
Nancy Knee, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 541 Main St, New London, NH 03257 Phone: 603-526-3000 Fax: 603-526-3621 | |
Kevin P Hannon, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 273 County Rd, New London, NH 03257 Phone: 603-526-2911 |